Abstract
Obese human subjects have increased protein-tyrosine phosphatase (PTPase) activity in adipose tissue that can dephosphorylate and inactivate the insulin receptor kinase. To extend these findings to skeletal muscle, we measured PTPase activity in the skeletal muscle particulate fraction and cytosol from a series of lean controls, insulin-resistant obese (body mass index > 30) nondiabetic subjects, and obese individuals with non-insulin-dependent diabetes. PTPase activities in subcellular fractions from the nondiabetic obese subjects were increased to 140-170% of the level in lean controls (P < 0.05). In contrast, PTPase activity in both fractions from the obese subjects with non-insulin-dependent diabetes was significantly decreased to 39% of the level in controls (P < 0.05). By immunoblot analysis, leukocyte antigen related (LAR) and protein-tyrosine phosphatase 1B had the greatest increase (threefold) in the particulate fraction from obese, nondiabetic subjects, and immunodepletion of this fraction using an affinity-purified antibody directed at the cytoplasmic domain of leukocyte antigen related normalized the PTPase activity when compared to the activity from control subjects. These findings provide further support for negative regulation of insulin action by specific PTPases in the pathogenesis of insulin resistance in human obesity, while other regulatory mechanisms may be operative in the diabetic state.
Full Text
The Full Text of this article is available as a PDF (398.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahmad F., Considine R. V., Goldstein B. J. Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest. 1995 Jun;95(6):2806–2812. doi: 10.1172/JCI117985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmad F., Goldstein B. J. Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol. 1995 May;268(5 Pt 1):E932–E940. doi: 10.1152/ajpendo.1995.268.5.E932. [DOI] [PubMed] [Google Scholar]
- Ahmad F., Goldstein B. J. Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. J Biol Chem. 1997 Jan 3;272(1):448–457. [PubMed] [Google Scholar]
- Ahmad F., Goldstein B. J. Purification, identification and subcellular distribution of three predominant protein-tyrosine phosphatase enzymes in skeletal muscle tissue. Biochim Biophys Acta. 1995 Apr 5;1248(1):57–69. doi: 10.1016/0167-4838(95)00003-d. [DOI] [PubMed] [Google Scholar]
- Ahmad F., Li P. M., Meyerovitch J., Goldstein B. J. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem. 1995 Sep 1;270(35):20503–20508. doi: 10.1074/jbc.270.35.20503. [DOI] [PubMed] [Google Scholar]
- Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Caro J. F. Clinical review 26: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 1991 Oct;73(4):691–695. doi: 10.1210/jcem-73-4-691. [DOI] [PubMed] [Google Scholar]
- Caro J. F., Dohm L. G., Pories W. J., Sinha M. K. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev. 1989 Dec;5(8):665–689. doi: 10.1002/dmr.5610050804. [DOI] [PubMed] [Google Scholar]
- Chernoff J., Schievella A. R., Jost C. A., Erikson R. L., Neel B. G. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2735–2739. doi: 10.1073/pnas.87.7.2735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cicirelli M. F., Tonks N. K., Diltz C. D., Weiel J. E., Fischer E. H., Krebs E. G. Microinjection of a protein-tyrosine-phosphatase inhibits insulin action in Xenopus oocytes. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5514–5518. doi: 10.1073/pnas.87.14.5514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care. 1992 Mar;15(3):318–368. doi: 10.2337/diacare.15.3.318. [DOI] [PubMed] [Google Scholar]
- Ding W., Zhang W. R., Sullivan K., Hashimoto N., Goldstein B. J. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. Biochem Biophys Res Commun. 1994 Jul 29;202(2):902–907. doi: 10.1006/bbrc.1994.2015. [DOI] [PubMed] [Google Scholar]
- Dohm G. L., Tapscott E. B., Pories W. J., Dabbs D. J., Flickinger E. G., Meelheim D., Fushiki T., Atkinson S. M., Elton C. W., Caro J. F. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 1988 Aug;82(2):486–494. doi: 10.1172/JCI113622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fischer E. H., Charbonneau H., Tonks N. K. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science. 1991 Jul 26;253(5018):401–406. doi: 10.1126/science.1650499. [DOI] [PubMed] [Google Scholar]
- Freeman R. M., Jr, Plutzky J., Neel B. G. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11239–11243. doi: 10.1073/pnas.89.23.11239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedman J. E., Caro J. F., Pories W. J., Azevedo J. L., Jr, Dohm G. L. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus. Metabolism. 1994 Aug;43(8):1047–1054. doi: 10.1016/0026-0495(94)90188-0. [DOI] [PubMed] [Google Scholar]
- Goldstein B. J. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor. 1993 Spring;3(1):1–15. [PubMed] [Google Scholar]
- Goodyear L. J., Giorgino F., Sherman L. A., Carey J., Smith R. J., Dohm G. L. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995 May;95(5):2195–2204. doi: 10.1172/JCI117909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gruppuso P. A., Boylan J. M., Posner B. I., Faure R., Brautigan D. L. Hepatic protein phosphotyrosine phosphatase. Dephosphorylation of insulin and epidermal growth factor receptors in normal and alloxan diabetic rats. J Clin Invest. 1990 Jun;85(6):1754–1760. doi: 10.1172/JCI114632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guan K. L., Haun R. S., Watson S. J., Geahlen R. L., Dixon J. E. Cloning and expression of a protein-tyrosine-phosphatase. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1501–1505. doi: 10.1073/pnas.87.4.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hashimoto N., Feener E. P., Zhang W. R., Goldstein B. J. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J Biol Chem. 1992 Jul 15;267(20):13811–13814. [PubMed] [Google Scholar]
- Hashimoto N., Goldstein B. J. Differential regulation of mRNAs encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C. Biochem Biophys Res Commun. 1992 Nov 16;188(3):1305–1311. doi: 10.1016/0006-291x(92)91373-x. [DOI] [PubMed] [Google Scholar]
- Hauguel-de Mouzon S., Peraldi P., Alengrin F., Van Obberghen E. Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology. 1993 Jan;132(1):67–74. doi: 10.1210/endo.132.1.8419148. [DOI] [PubMed] [Google Scholar]
- Häring H. U., Mehnert H. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle. Diabetologia. 1993 Mar;36(3):176–182. doi: 10.1007/BF00399946. [DOI] [PubMed] [Google Scholar]
- Kasuga M., White M. F., Kahn C. R. Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system. Methods Enzymol. 1985;109:609–621. doi: 10.1016/0076-6879(85)09118-2. [DOI] [PubMed] [Google Scholar]
- Kenner K. A., Anyanwu E., Olefsky J. M., Kusari J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem. 1996 Aug 16;271(33):19810–19816. doi: 10.1074/jbc.271.33.19810. [DOI] [PubMed] [Google Scholar]
- Kenner K. A., Hill D. E., Olefsky J. M., Kusari J. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. J Biol Chem. 1993 Dec 5;268(34):25455–25462. [PubMed] [Google Scholar]
- Kolterman O. G., Insel J., Saekow M., Olefsky J. M. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980 Jun;65(6):1272–1284. doi: 10.1172/JCI109790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuhné M. R., Pawson T., Lienhard G. E., Feng G. S. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem. 1993 Jun 5;268(16):11479–11481. [PubMed] [Google Scholar]
- Kulas D. T., Zhang W. R., Goldstein B. J., Furlanetto R. W., Mooney R. A. Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR. J Biol Chem. 1995 Feb 10;270(6):2435–2438. doi: 10.1074/jbc.270.6.2435. [DOI] [PubMed] [Google Scholar]
- Kusari J., Kenner K. A., Suh K. I., Hill D. E., Henry R. R. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J Clin Invest. 1994 Mar;93(3):1156–1162. doi: 10.1172/JCI117068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Lammers R., Bossenmaier B., Cool D. E., Tonks N. K., Schlessinger J., Fischer E. H., Ullrich A. Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem. 1993 Oct 25;268(30):22456–22462. [PubMed] [Google Scholar]
- Li P. M., Zhang W. R., Goldstein B. J. Suppression of insulin receptor activation by overexpression of the protein-tyrosine phosphatase LAR in hepatoma cells. Cell Signal. 1996 Nov;8(7):467–473. doi: 10.1016/s0898-6568(96)00101-5. [DOI] [PubMed] [Google Scholar]
- McGuire M. C., Fields R. M., Nyomba B. L., Raz I., Bogardus C., Tonks N. K., Sommercorn J. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes. 1991 Jul;40(7):939–942. doi: 10.2337/diab.40.7.939. [DOI] [PubMed] [Google Scholar]
- Meyerovitch J., Backer J. M., Csermely P., Shoelson S. E., Kahn C. R. Insulin differentially regulates protein phosphotyrosine phosphatase activity in rat hepatoma cells. Biochemistry. 1992 Oct 27;31(42):10338–10344. doi: 10.1021/bi00157a023. [DOI] [PubMed] [Google Scholar]
- Meyerovitch J., Backer J. M., Kahn C. R. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. J Clin Invest. 1989 Sep;84(3):976–983. doi: 10.1172/JCI114261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Milarski K. L., Saltiel A. R. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem. 1994 Aug 19;269(33):21239–21243. [PubMed] [Google Scholar]
- Møller N. P., Møller K. B., Lammers R., Kharitonenkov A., Hoppe E., Wiberg F. C., Sures I., Ullrich A. Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon. J Biol Chem. 1995 Sep 29;270(39):23126–23131. doi: 10.1074/jbc.270.39.23126. [DOI] [PubMed] [Google Scholar]
- Noguchi T., Matozaki T., Horita K., Fujioka Y., Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol. 1994 Oct;14(10):6674–6682. doi: 10.1128/mcb.14.10.6674. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rabinowitz D. Some endocrine and metabolic aspects of obesity. Annu Rev Med. 1970;21:241–258. doi: 10.1146/annurev.me.21.020170.001325. [DOI] [PubMed] [Google Scholar]
- Sap J., D'Eustachio P., Givol D., Schlessinger J. Cloning and expression of a widely expressed receptor tyrosine phosphatase. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6112–6116. doi: 10.1073/pnas.87.16.6112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sredy J., Sawicki D. R., Flam B. R., Sullivan D. Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor. Metabolism. 1995 Aug;44(8):1074–1081. doi: 10.1016/0026-0495(95)90107-8. [DOI] [PubMed] [Google Scholar]
- Streuli M., Krueger N. X., Hall L. R., Schlossman S. F., Saito H. A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J Exp Med. 1988 Nov 1;168(5):1523–1530. doi: 10.1084/jem.168.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tonks N. K., Cicirelli M. F., Diltz C. D., Krebs E. G., Fischer E. H. Effect of microinjection of a low-Mr human placenta protein tyrosine phosphatase on induction of meiotic cell division in Xenopus oocytes. Mol Cell Biol. 1990 Feb;10(2):458–463. doi: 10.1128/mcb.10.2.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tonks N. K., Diltz C. D., Fischer E. H. Purification and assay of CD45: an integral membrane protein-tyrosine phosphatase. Methods Enzymol. 1991;201:442–451. doi: 10.1016/0076-6879(91)01040-9. [DOI] [PubMed] [Google Scholar]
- White M. F., Kahn C. R. The insulin signaling system. J Biol Chem. 1994 Jan 7;269(1):1–4. [PubMed] [Google Scholar]
- Worm D., Vinten J., Staehr P., Henriksen J. E., Handberg A., Beck-Nielsen H. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia. 1996 Oct;39(10):1208–1214. doi: 10.1007/BF02658508. [DOI] [PubMed] [Google Scholar]
- Xiao S., Rose D. W., Sasaoka T., Maegawa H., Burke T. R., Jr, Roller P. P., Shoelson S. E., Olefsky J. M. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem. 1994 Aug 19;269(33):21244–21248. [PubMed] [Google Scholar]
- Yamauchi K., Milarski K. L., Saltiel A. R., Pessin J. E. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):664–668. doi: 10.1073/pnas.92.3.664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang W. R., Li P. M., Oswald M. A., Goldstein B. J. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR. Mol Endocrinol. 1996 May;10(5):575–584. doi: 10.1210/mend.10.5.8732688. [DOI] [PubMed] [Google Scholar]